title: Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population.
abstract: OBJECTIVE
  While many studies have shown an association between the gene coding for adiponectin (ADIPOQ) and adiponectin levels, much more controversy surrounds its association with metabolic traits such as insulin resistance, obesity and type 2 diabetes. Furthermore, very few studies have looked into the relations between ADIPOQ variants and risk of cardiovascular disease. The present study assessed the influence of four common ADIPOQ Single Nucleotide Polymorphisms (SNPs), rs17300539 (-11391G→A), rs266729 (-11377C→G), rs2241766 (+45T→G) and rs1501299 (+276G→T) on the risk of myocardial infarction and type 2 diabetes.
  
  
  METHODS
  and
  
  
  RESULTS
  A large genetic association case-control study was conducted in 2008 Italians, including patients with myocardial infarction, type 2 diabetes, or both, and a reference group of healthy controls. Homozygotes TT for the rs1501299 (+276) had half the risk of either myocardial infarction alone or in association with type 2 diabetes when compared to the carriers of the G allele (OR = 0.58, p =0.01, and OR = 0.55, p =0.006 respectively). SNPs rs17300539 (-11391), rs266729 (-11377) and rs2241766 (+45) showed no significant association with any of the three case groups.
  
  
  CONCLUSIONS
  These results suggest that homozygotes TT for the adiponectin polymorphism rs1501299 (+276) are protected from the risk of myocardial infarction.
authors.affiliation: Division of Genetics and Molecular Medicine, King's College London, London, UK, Department of Cardiovascular Research, Mario Negri Institute for Pharmacological Research, Milano, Italy.
authors.forename: Benedetta D
authors.initials: BD
authors.lastname: Chiodini
authors.forename: Claudia
authors.initials: C
authors.lastname: Specchia
authors.forename: Francesca
authors.initials: F
authors.lastname: Gori
authors.forename: Simona
authors.initials: S
authors.lastname: Barlera
authors.forename: Andria
authors.initials: A
authors.lastname: D'Orazio
authors.forename: Silvia
authors.initials: S
authors.lastname: Pietri
authors.forename: Luisa
authors.initials: L
authors.lastname: Crociati
authors.forename: Antonio
authors.initials: A
authors.lastname: Nicolucci
authors.forename: Monica
authors.initials: M
authors.lastname: Franciosi
authors.forename: Stefano
authors.initials: S
authors.lastname: Signorini
authors.forename: Paolo
authors.initials: P
authors.lastname: Brambilla
authors.forename: Maria
authors.initials: M
authors.lastname: Grazia Franzosi
mesh_terms: D052242:Adiponectin / Q000235:genetics; D000368:Aged; D000704:Analysis of Variance; D016022:Case-Control Studies; D016009:Chi-Square Distribution; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D006720:Homozygote; D006801:Humans; D007558:Italy / Q000453:epidemiology; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000453:epidemiology / Q000235:genetics*; D016017:Odds Ratio; D020641:Polymorphism, Single Nucleotide; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: C499918:ADIPOQ protein, human; D052242:Adiponectin